Research Grants support investigators pursuing fundamental and applied MS research to advance roadmap goals of stopping disease activity, restoring function, and preventing new cases of MS.
The targeted RFA for early detection and diagnosis of MS in the 2026–2027 winter cycle has launched, replacing the previous planned-launch notice. Funding-opportunity email signup now uses a research mailing list instead of requests to msresearch@nmss.org.
Postdoctoral Fellowships from the National Multiple Sclerosis Society support investigators and doctors with MS research training to prepare them for independent careers contributing to the effort to end MS.
The National Multiple Sclerosis Society’s Commercial Research Funding Opportunity supports innovative research to develop new MS therapies and diagnostics, bridging discovery and commercial development.
Discovery Grants support researchers pursuing preliminary studies and proof-of-concept experiments in psoriatic disease and related comorbidities to launch new programs competitive for longer-term funding.
New Investigator Grant - National Scleroderma Foundation supports promising new researchers with basic, clinical, and health services research funding to understand scleroderma and improve treatments.
Career Transition Fellowships support early-career MS scientists through advanced postdoctoral training and new faculty research to build independence and advance priorities for stopping, reversing, and preventing MS.